SERA7

SERA7 (PF3D7_0207400) is a member of the P. falciparum serine repeat antigen (SERA) family whose transcript is synthesized late in the erythrocytic cycle but whose gene is dispensable for blood-stage growth, as demonstrated by successful targeted disruption in contrast to the essential centrally clustered SERA4-6 (PMID:12228245). Its late-stage expression is co-regulated with other SERA members and driven by the transcription factor PfAP2-I, which binds the sera7 promoter in schizonts (PMID:31856180, PMID:32198457). The most direct functional insight derives from the P. berghei ortholog PbSERA4, which is proteolytically processed in liver and blood stages and contributes to efficient egress of merozoites from liver-stage infected cells, such that its disruption yields viable blood-stage parasites but a reduced capacity to initiate blood-stage infection after mosquito transmission (PMID:32956401). Sequence and domain analysis positions SERA7 as a cysteine-type papain-like protease bearing conserved catalytic residues, distinguishing it from the serine-type SERA members (PMID:32956401). Beyond these findings, the enzymatic activity, substrates, and in-parasite function of the P. falciparum protein itself have not been directly characterized in the available corpus.

1. 2002 Medium

   Establishing whether SERA7 is required for asexual replication was needed to place it within the essential-versus-redundant architecture of the SERA locus; its successful knockout showed it is dispensable for the blood-stage cycle, unlike the essential central SERA members.

   Evidence Targeted gene disruption in P. falciparum blood stages with growth-phenotype assessment

   PMID:12228245

   Open questions at the time

   • Dispensability in blood stages does not exclude a role in other life-cycle stages
   • No protein-level detection to link genotype to expressed product
2. 2002 Medium

   Defining the timing and level of SERA7 expression addressed whether it behaves like the up-regulated central SERA members; RT-PCR and microarray showed late-cycle mRNA but no substantial up-regulation, and antibodies failed to confirm blood-stage protein.

   Evidence RT-PCR and microarray profiling plus western blotting with SERA-specific antibodies in P. falciparum

   PMID:12228245

   Open questions at the time

   • Absence of antibody signal leaves protein expression in blood stages unresolved
   • No information on translation efficiency or protein turnover
3. 2014 Low

   Biochemical characterization of the recombinant ectodomain tested how the protein is processed and folded; it migrated at ~30 kDa consistent with C-terminal cleavage and lacked prominent heat-labile conformational epitopes.

   Evidence Recombinant expression, SDS-PAGE/western blot, and heat-denaturation ELISA with immune sera in a P. falciparum context

   PMID:24620899

   Open questions at the time

   • Recombinant biochemistry without in-parasite functional validation
   • Processing pattern of native parasite protein not established
   • No enzymatic activity assessed
4. 2017 Low

   Phylogenetic reconstruction asked where SERA7 sits in the evolution of the family; it placed SERA7 (with SERA6) near the ancestral cysteine-type gene from which serine-type SERAs derived.

   Evidence Phylogenetic inference within a study of SERA5 function in P. falciparum

   PMID:28683142

   Open questions at the time

   • Computational inference with no direct experiment on SERA7
   • Ancestral placement does not establish current function
5. 2020 Low

   Determining the enzyme class predicted for SERA7 clarified whether it is a functional protease; catalytic-residue analysis of the P. berghei ortholog identified an intact papain-family cysteine protease catalytic set, marking it as a cysteine-type rather than serine-type member.

   Evidence Sequence alignment and structural annotation of catalytic residues in P. berghei PbSERA4 (also inferred for P. falciparum SERA7)

   PMID:32956401

   Open questions at the time

   • No in vitro enzymatic assay confirming catalytic activity
   • Substrates and cleavage specificity unknown
6. 2020 High

   The functional role of the ortholog was resolved in P. berghei, addressing what SERA7-like proteases do in vivo; PbSERA4 is processed in liver and blood stages and its loss impairs egress from liver cells and reduces establishment of blood-stage infection after transmission.

   Evidence Ortholog-specific antisera, fluorescent tagging, gene disruption, in vivo infection and egress assays in P. berghei ANKA

   PMID:32956401

   Open questions at the time

   • Phenotype defined in P. berghei; equivalent liver-stage role of P. falciparum SERA7 not tested
   • Molecular substrates driving egress not identified
7. 2020 Medium

   Placing SERA7 in the transcriptional regulatory network identified an upstream regulator; single-cell RNA-seq showed co-regulated late-stage expression with SERA4/SERA5, and ChIP-seq showed PfAP2-I, but not PfAP2-G, binds the sera7 promoter.

   Evidence scRNA-seq with RNA-FISH validation and reciprocal PfAP2-G/PfAP2-I ChIP-seq in P. falciparum schizonts (3D7)

   PMID:31856180 PMID:32198457

   Open questions at the time

   • Promoter binding does not establish functional dependence of expression on PfAP2-I
   • Regulation in stages other than schizonts not addressed

• Whether the P. falciparum SERA7 protein is enzymatically active, what it cleaves, and whether it performs the egress-related role demonstrated for its P. berghei ortholog remain unresolved.
• No in vitro protease activity or substrate identification for SERA7
• No demonstration of native protein expression or localization in P. falciparum
• Liver-stage function untested in P. falciparum